EuropaWire3 天
TUM and UCSF Collaborate on Engineered Immune Cells to Target Inflammatory Disorders
Researchers from UCSF and the Technical University of Munich (TUM) have developed engineered regulatory immune cells to precisely modulate the im ...
studyfinds3 天
Scientists close to creating ‘simple pill’ that cures diabetes
Imagine a world where diabetes could be treated with a simple pill that essentially reprograms your body to produce insulin ...
Noom Offers Oral Medications For Weight Loss Starting at $29
A $29 entry price helps provide accessibility for people pursuing weight loss goalsService includes all features of Noom Med ...
Big News Network.com4 天
Telomir Pharmaceuticals Raises $1 Million at $7 per Share in a No-Warrant, Restricted ...
Progeria Studies: Investigating Telomir-1's effects on telomere stability and accelerated aging in human cell lines and nematode models. Type 2 Diabetes: Further validating Telomir-1's ability to ...
Bio-Path Holdings Outlines Rationale for Development of BP1001-A as Potential Treatment for ...
Extensive Scientific Evidence Supporting Growth Factor Receptor Bound Protein-2 (Grb2) as Fundamental Link in Insulin ResistanceReallocates ...
News Medical on MSN5 天
Scientists identify potential therapeutic targets for diabetic kidney disease
New potential therapeutic targets have been identified for diabetic kidney disease (DKD) - the leading cause of kidney ...
University of Bristol6 天
New targets for diabetic kidney disease could prevent end stage kidney failure
New potential therapeutic targets have been identified for diabetic kidney disease (DKD) - the leading cause of kidney ...